Ironwood Pharmaceuticals | IRWD - Equity Capital And Reserves



Ironwood Pharmaceuticals reported $-301245000 in Equity Capital and Reserves for its fiscal quarter ending in December of 2024.


Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 822.38M 57.14M Jun/2025
Agios Pharmaceuticals USD 1.37B 96.97M Jun/2025
Almirall EUR 1.46B 37.19M Jun/2025
Alnylam Pharmaceuticals USD 250.59M 135.16M Jun/2025
Amarin USD 473.69M 12.49M Mar/2025
Ardelyx USD 139.53M 33.76M Jun/2025
Astellas Pharma JPY 1.48T 31.46B Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
Charles River Laboratories USD 3.31B 119.03M Jun/2025
Exact Sciences USD 2.47B 72.51M Jun/2025
Halozyme Therapeutics USD 332.75M 149.52M Jun/2025
Incyte USD 4.17B 503.34M Jun/2025
Ironwood Pharmaceuticals USD -301245000 10.09M Dec/2024
MacroGenics USD 46.62M 69.44M Jun/2025
Moderna USD 9.4B 667M Jun/2025
Myriad Genetics USD 704.9M 3.8M Mar/2025
Pacira USD 757.77M 40.77M Jun/2025
PTC Therapeutics USD -206546000 20.79M Jun/2025
Sarepta Therapeutics USD 1.36B 214.66M Jun/2025
Takeda JPY 6.87T 69.82B Jun/2025
Ultragenyx Pharmaceutical USD 151.29M 7.04M Jun/2025